Clinical Trial Update: Nivolumab and Yttrium Y 90 Glass Microspheres in Treating Patients With Advanced Liver Cancer [Phase 1]

View source ↗

Summary

Phase 1 trial updating use of nivolumab with Yttrium-90 glass microspheres in advanced hepatocellular carcinoma; study completed with results posted in 2020.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• Yttrium-90 glass microspheres (yttrium-90 glass microspheres)
• nivolumab (nivolumab)

Snippet

Sponsor: Northwestern University | Conditions: Stage IIIA Hepatocellular Carcinoma, Stage IIIB Hepatocellular Carcinoma | Phase 1 | Status: COMPLETED | Results posted: 2020-08-11